# Clinical Evaluation of the iMOST-X1 Hematology Analyzer - Matrix Study

> **NCT04778553** · — · COMPLETED · sponsor: **Essenlix Corporation** · enrollment: 60 (actual)

## Conditions studied

- Hematologic Tests

## Interventions

- **DIAGNOSTIC_TEST:** iMOST X-1 Hematology Analyzer

## Key facts

- **NCT ID:** NCT04778553
- **Lead sponsor:** Essenlix Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-19
- **Primary completion:** 2020-12-09
- **Final completion:** 2021-01-21
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04778553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04778553, "Clinical Evaluation of the iMOST-X1 Hematology Analyzer - Matrix Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04778553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*